Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population | Zendy

RiLi Ge | Zendy; Yujuan Qi | Zendy; Sen Cui | Zendy; Yingzhong Yang | Zendy; Jingqi Han | Zendy; Baojia Cai | Zendy; Cun-Fang Sheng | Zendy; Yan Ma | Zendy; Tana Wuren | Zendy

Open Access

Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population

Author(s) -

RiLi Ge,

Yujuan Qi,

Sen Cui,

Yingzhong Yang,

Jingqi Han,

Baojia Cai,

Cun-Fang Sheng,

Yan Ma,

Tana Wuren

Publication year - 2013

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.119319

Subject(s) - ercc1 , oncology , biology , folfox , oxaliplatin , medicine , cancer research , gastroenterology , microbiology and biotechnology , genetics , cancer , gene , dna repair , colorectal cancer , nucleotide excision repair

The excision repair cross-complementation group 1 (ERCC1) codon 118 C/T polymorphism has been associated with clinical outcome in cancer patients treated with platinum chemotherapy. Ethnic differences in the frequency of this polymorphism have been observed in Caucasian and African populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research